Upfront high-dose chemotherapy combined with autologous stem cell transplantation: Potential survival benefit for patients with high-risk diffuse large B-cell lymphoma

In patients with diffuse large B-cell lymphoma (DLBCL) classified as high-intermediate risk or high risk using the International Prognosis Index, the efficacy of high-dose chemotherapy combined with upfront autologous stem cell transplantation (HDT/ASCT) remains controversial in the rituximab era. I...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Oncol Lett
Hoofdauteurs: Nakaya, Aya, Fujita, Shinya, Satake, Atsushi, Nakanishi, Takahisa, Azuma, Yoshiko, Tsubokura, Yukie, Hotta, Masaaki, Yoshimura, Hideaki, Ishii, Kazuyoshi, Ito, Tomoki, Nomura, Shosaku
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: D.A. Spandidos 2017
Onderwerpen:
Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5588041/
https://ncbi.nlm.nih.gov/pubmed/28927150
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6589
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items